ConductScience.org, home

Paper41867752

Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAP.

White WL and 7 others. bioRxiv, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAP. Papers, record 41867752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41867752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAP.
PubMed
Journal
bioRxiv
PubMed
Year
2026
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1White WLWilliam Lhttps://orcid.org/0009-0004-0041-2125
2Moseley EEdward
3Tremblay JMJacqueline M
4Reilly JJackson
5Da'dara AAAkram A
6Skelly PJPatrick J
7Cowen LJLenore J
8Shoemaker CBCharles Bhttps://orcid.org/0000-0001-9738-1361

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K12 GM133314NIGMS NIH HHSUnited StatesK12GM133314PubMedNIH RePORTER
R01 AI125704NIAID NIH HHSUnited StatesR01AI125704PubMedNIH RePORTER

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110698934Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire.EMBO J2000https://conductscience.org/library/papers/10698934PubMed
231894001Development of therapeutic antibodies for the treatment of diseases.J Biomed Sci2020https://conductscience.org/library/papers/31894001PubMed
329035372MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets.Nat Biotechnol2017https://conductscience.org/library/papers/29035372PubMed
439433212Nanobodies: From High-Throughput Identification to Therapeutic Development.Mol Cell Proteomics2024https://conductscience.org/library/papers/39433212PubMed
515355155Properties of the Hubert-Arabie adjusted Rand index.Psychol Methods2004https://conductscience.org/library/papers/15355155PubMed
635563400Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.Int J Mol Sci2022https://conductscience.org/library/papers/35563400PubMed
736798133A novel, non-neuronal acetylcholinesterase of schistosome parasites is essential for definitive host infection.Front Immunol2023https://conductscience.org/library/papers/36798133PubMed
835803998Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes.Sci Rep2022https://conductscience.org/library/papers/35803998PubMed
926069265Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data.Bioinformatics2015https://conductscience.org/library/papers/26069265PubMed
1032574157Somatic hypermutation analysis for improved identification of B cell clonal families from next-generation sequencing data.PLoS Comput Biol2020https://conductscience.org/library/papers/32574157PubMed
1139166870Single domain antibody: Development and application in biotechnology and biopharma.Immunol Rev2024https://conductscience.org/library/papers/39166870PubMed
1241193399From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies.MAbs2025https://conductscience.org/library/papers/41193399PubMed
1334990480Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies.PLoS Pathog2022https://conductscience.org/library/papers/34990480PubMed
1422238680A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model.PLoS One2012https://conductscience.org/library/papers/22238680PubMed
1527365031Antibodies and antibody-derived analytical biosensors.Essays Biochem2016https://conductscience.org/library/papers/27365031PubMed
1623435259Predicting the molecular complexity of sequencing libraries.Nat Methods2013https://conductscience.org/library/papers/23435259PubMed
1734478129Therapeutic Antibodies: An Overview.Methods Mol Biol2022https://conductscience.org/library/papers/34478129PubMed
1828785006A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.Sci Rep2017https://conductscience.org/library/papers/28785006PubMed
1924618469pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires.Bioinformatics2014https://conductscience.org/library/papers/24618469PubMed
2023813602Schistosomiasis chemotherapy.Angew Chem Int Ed Engl2013https://conductscience.org/library/papers/23813602PubMed

See all 33 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41867752

GET https://conductscience.org/api/papers/v1/41867752/references?page=2